300
Invokana, Jardiance, and Farxiga all work on this receptor in the kidney to promote renal excretion of glucose and lower blood sugar. Watch out, they have a risk of causing UTI, pyelo, hypotension, hyperkalemia, ketoacidosis, and AKI.
What is the SGLT-2 receptor.